Fisher & Paykel Healthcare (NZSE:FPH) Operating Cash Flow per Share : NZ$0.67 (TTM As of Sep. 2023)

View and export this data going back to 1979. Start your Free Trial

What is Fisher & Paykel Healthcare Operating Cash Flow per Share?

Fisher & Paykel Healthcare's operating cash flow per share for the six months ended in Sep. 2023 was NZ$0.27. Fisher & Paykel Healthcare's operating cash flow per share for the trailing twelve months (TTM) ended in Sep. 2023 was NZ$0.67.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Fisher & Paykel Healthcare was 96.80% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -9.70% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 3.30% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 15.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Fisher & Paykel Healthcare's Operating Cash Flow per Share or its related term are showing as below:

NZSE:FPH' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -15.7 Med: 14.7 Max: 35.8
Current: -9.7

During the past 13 years, Fisher & Paykel Healthcare's highest 3-Year average Operating Cash Flow per Share Growth Rate was 35.80% per year. The lowest was -15.70% per year. And the median was 14.70% per year.

NZSE:FPH's 3-Year OCF Growth Rate is ranked worse than
67.74% of 682 companies
in the Medical Devices & Instruments industry
Industry Median: 3.65 vs NZSE:FPH: -9.70

Fisher & Paykel Healthcare Operating Cash Flow per Share Historical Data

The historical data trend for Fisher & Paykel Healthcare's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fisher & Paykel Healthcare Operating Cash Flow per Share Chart

Fisher & Paykel Healthcare Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Operating Cash Flow per Share

Get a 7-Day Free Trial

0.44

0.56

1.08

0.56

0.41

Fisher & Paykel Healthcare Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Operating Cash Flow per Share	Get a 7-Day Free Trial															0.22	0.34	-	0.41	0.27

Competitive Comparison of Fisher & Paykel Healthcare's Operating Cash Flow per Share

For the Medical Instruments & Supplies subindustry, Fisher & Paykel Healthcare's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fisher & Paykel Healthcare's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Fisher & Paykel Healthcare's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Fisher & Paykel Healthcare's Price-to-Operating-Cash-Flow falls into.

Fisher & Paykel Healthcare Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Fisher & Paykel Healthcare's Operating Cash Flow per Share for the fiscal year that ended in Mar. 2023 is calculated as

Operating Cash Flow per Share (A: Mar. 2023 )	=	Cash Flow from Operations (A: Mar. 2023 )	/	Shares Outstanding (Diluted Average) (A: Mar. 2023 )
	=	238.2	/	582.093
	=	0.41

Fisher & Paykel Healthcare's Operating Cash Flow per Share for the quarter that ended in Mar. 2023 is calculated as

Operating Cash Flow per Share (Q: Sep. 2023 )	=	Cash Flow from Operations (Q: Sep. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Sep. 2023 )
	=	156.5	/	583.152
	=	0.27

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was NZ$0.67

Fisher & Paykel Healthcare Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Fisher & Paykel Healthcare's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Fisher & Paykel Healthcare (NZSE:FPH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Fisher & Paykel Healthcare Corp Ltd (NZSE:FPH) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

FSPKF:USA FPLB:Germany FPH:Australia

Address

15 Maurice Paykel Place, East Tamaki, Auckland, NTL, NZL, 2013

Website

https://www.fphcare.com

Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use humidifiers, masks and related consumables and the number three player in the at-home treatment of sleep apnoea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns 42% of its revenue in the U.S., 32% in Europe, 18% in Asia-Pacific and the remaining 8% in emerging markets. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand and Mexico and has a multichannel distribution model.